搜索页_+Sorafenib

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“SpringerLink电子期刊”中，命中：1,099条，耗时：小于0.01 秒

1. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study

作者： Fengyong Liu ; Zhiqiang Meng ; Guoliang Shao ; Jianhua Wang…

关键词：Hepatocellular carcinoma ; Unresectable ; Advanced ; Sorafenib ; TACE ; transarterial chemoembolization ; Observational studies ; Survival ; neoplasm staging

刊名：Molecular Biology Reports

出版年：2017

2. Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature

作者： Catherine Atkin ; Philip Earwaker ; Arvind Pallan ; Shishir Shetty…

关键词：Sorafenib ; Hepatocellular carcinoma ; Hepatitis C virus infection

刊名：BMC Gastroenterology

出版年：2017

3. FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib

作者： Lixia Gao ; Xuli Wang ; Yaoliang Tang…

关键词：FGF19 ; FGFR4 ; Hepatocellular carcinoma ; Drug resistance ; Sorafenib ; Synergistic effect

刊名：Journal of Experimental & Clinical Cancer Research

出版年：2017

4. Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib

作者： A. Lamarca ; O. Abdel-Rahman ; I. Salu ; M. G. McNamara…

关键词：Hepatocellular carcinoma (HCC) ; Sorafenib ; Biomarker ; Clinical ; Survival ; Toxicity

刊名：Clinical and Translational Oncology

出版年：2017

5. Evaluation of sorafenib for advanced hepatocellular carcinoma with low α-fetoprotein in arrival time parametric imaging using contrast-enhanced ultrasonography

作者： Kazue Shiozawa ; Manabu Watanabe ; Takashi Ikehara…

关键词：Hepatocellular carcinoma ; Sorafenib ; Contrast ; enhanced ultrasonography ; Arrival time parametric imagingα ; Fetoprotein

刊名：Journal of Medical Ultrasonics

出版年：2017

6. Sorafenib versus sunitinib as first-line treatment agents in Chinese patients with metastatic renal cell carcinoma: the largest multicenter retrospective analysis of survival and prognostic factors

作者： Hai-Liang Zhang ; Xi-Nan Sheng ; Xue-Song Li ; Hong-Kai Wang ; Zhi-Hong Chi…

关键词：Metastatic renal cell carcinoma ; Sorafenib ; Sunitinib ; Prognosis ; Survival

刊名：BMC Cancer

出版年：2017

7. C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells

作者： Shanshan Jiang ; Qian Wang ; Meiqing Feng…

关键词：HCC ; Orafenib ; C2 ; ceramide ; Apoptosis ; PI3K/AKT/mTOR ; EMT

刊名：Applied Microbiology and Biotechnology

出版年：2017

8. Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

作者： Ghassan K. Abou-Alfa ; Chia-Jui Yen ; Chih-Hung Hsu…

刊名：Cancer Chemotherapy and Pharmacology

出版年：2017

9. Successful recovery from a subclavicular ulcer caused by lenvatinib for thyroid cancer: a case report

作者： Morimasa Kitamura ; Tomomasa Hayashi ; Chiaki Suzuki…

关键词：Lenvatinib ; Sorafenib ; Antiangiogenic tyrosine kinase inhibitor ; Thyroid cancer ; Surgery

刊名：World Journal of Surgical Oncology

出版年：2017

10. Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma

作者： Giovan Giuseppe Di Costanzo ; Raffaella Tortora ; Filomena Morisco…

刊名：Targeted Oncology

出版年：2017

按检索点细分(1099)

题名(749)

关键词(362)

文摘(600)

按出版年细分(1099)

2017年(24)

2016年(102)

2015年(159)

2014年(162)

2013年(149)

2012年(134)

2011年(81)

2010年(99)

2009年(81)

2008年(44)

2007年(42)

2006年(21)

2005年(1)